SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is experiencing high volatility as investors weigh strong revenue growth and a massive $104 billion backlog against ongoing concerns regarding high capital expenditures and debt. The community remains deeply divided, with bulls pointing to accelerating AI infrastructure demand while bears express skepticism over sustained cash burn and profitability.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is seeing significant social media activity following an earnings report that featured a revenue guidance raise and bottom-line outperformance, fueling intense debate between bulls citing AI demand and shorts highlighting governance concerns. Investors are actively discussing the stock's volatility and the disparity between its strong financial outlook and its relatively subdued market reaction.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors aggressively monitor the highly anticipated 80th event trigger for its REGAL Phase 3 clinical trial, with community sentiment sharply divided between buyout speculation and skepticism over the extended trial timeline. The company's recent filing highlighting strong cash reserves, minimal dilution, and expanded preclinical work in pancreatic cancer has intensified community debate, as traders weigh these bullish fundamentals against the binary risks of an imminent final analysis.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony ($UAMY) is trending following a significant quarterly revenue miss and a reduction in full-year guidance, which has fueled widespread investor frustration and concerns over management's execution. While some in the community see the current price drop as a discount for long-term holders, others are actively debating the company's reliance on government contracts and the lack of clarity regarding its strategic pivot toward domestic independence.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Firefly Aerospace is seeing increased trading activity as investors speculate on potential government contracts and upcoming earnings, with the community closely tracking its competitive position relative to other major players in the space sector. Market participants are actively discussing the impact of broader industry developments and heavy institutional interest as the stock navigates a volatile period leading into its next financial update.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is seeing elevated volatility as investors weigh strong earnings and data center demand against sector-wide concerns, including potential trade restrictions on optical components. The community remains divided, with many traders actively discussing the stock's long-term growth prospects as a photonics leader versus the risk of a technical correction.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending following a strong quarterly earnings report that featured a double beat on revenue and earnings, driven by robust store traffic and growth in same-restaurant sales. The community is actively debating the stock's premium valuation versus its long-term potential as a category-leading national brand, while investors closely monitor institutional sentiment and guidance.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending following impressive quarterly earnings that featured strong revenue growth and increased financial guidance, driving significant investor optimism. The community is actively discussing the company's manufacturing expansion and its role in critical defense and aerospace supply chains, with many expressing bullish sentiment on its long-term growth potential.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors weigh explosive demand for AI infrastructure against concerns over high capital expenditures and dilution risks, with the community closely tracking upcoming earnings for validation. The stock remains a focal point for intense debate, as market participants actively bet on a potential short squeeze while monitoring the influence of high-profile short-sellers and institutional stake-building.

NextNav, Inc. engages in development of positioning, navigation, and timing solutions. Its products include NextNav Pinnacle, NextNav 3D, and NextNav TerraPoiNT. The company was founded by Ganesh Pattabiraman and Arun Raghupathy in May 2021 and is headquartered in Reston, VA.

NextNav Inc

NextNav is trending due to heightened investor anticipation surrounding the FCC's potential approval of its spectrum reconfiguration, which remains a key catalyst despite recent legislative and industry-driven delays. The community is actively debating the significance of ongoing regulatory processes and spectrum valuation, with sentiment currently split between high-conviction bullishness regarding the company's PNT technology and concerns over the complex, long-term political hurdles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Daxor (NASDAQ:DXR) Stock Price Up 1.3%  - What's Next?

Daxor (NASDAQ:DXR) Trading Up 1.3% - Here's Why...

Daxor Corporation (NASDAQ:DXR) Short Interest Update

Daxor Corporation (NASDAQ:DXR - Get Free Report) saw a large growth in short interest during the month of March. As of March 13th, there was short interest totaling 9,006 shares, a growth of 149.8...

Daxor Details Portable FDA-Cleared Blood Volume Analyzer, 'Razor-and-Blades' Kit Growth at iAccess Alpha

Daxor (NASDAQ:DXR) used its presentation at the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 to outline its focus on blood volume analysis and the company's commercialization...

Daxor (NYSEAMERICAN:DXR) Share Price Passes Below 200-Day Moving Average - Here's What Happened

Daxor (NYSEAMERICAN:DXR) Share Price Passes Below 200 Day Moving Average - Here's Why...

Short Interest in Daxor Corporation (NASDAQ:DXR) Decreases By 44.0%

Daxor Corporation (NASDAQ:DXR - Get Free Report) was the recipient of a large decrease in short interest in February. As of February 13th, there was short interest totaling 3,761 shares, a decrease...

Daxor (NYSEAMERICAN:DXR) Share Price Crosses Below Two Hundred Day Moving Average - Time to Sell?

Daxor (NYSEAMERICAN:DXR) Shares Cross Below Two Hundred Day Moving Average - Here's What Happened...

Daxor (NYSEAMERICAN:DXR) Stock Crosses Below Two Hundred Day Moving Average - Time to Sell?

Daxor (NYSEAMERICAN:DXR) Stock Crosses Below Two Hundred Day Moving Average - Time to Sell...

Daxor (NYSEAMERICAN:DXR) Stock Passes Below 200 Day Moving Average - Time to Sell?

Daxor (NYSEAMERICAN:DXR) Stock Price Passes Below Two Hundred Day Moving Average - Should You Sell...

Daxor (NASDAQ:DXR) Stock Price Up 0.6% - Time to Buy?

Daxor (NASDAQ:DXR) Trading Up 0.6% - Here's What Happened...

Daxor Corporation (NASDAQ:DXR) Sees Large Increase in Short Interest

Daxor Corporation (NASDAQ:DXR - Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 8,248...

DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.

Daxor Corp.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

DXRDaxor Corp.

Fundamentals

Connect Stocktwits to ChatGPT

Latest DXR News